Catarina Xavier
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 39
- Radiopharmaceutical Chemistry and Applications 37
- Medical Imaging Techniques and Applications 11
- Oncology 28
- HER2/EGFR in Cancer Research 13
- Peptidase Inhibition and Analysis 9
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Nick DevoogdtVicky CaveliersTony LahoutteSerge MuyldermansMatthias D’HuyvetterIlse VaneyckenMarleen KeyaertsSam Massa
- Journals
- Journal of Nuclear Medicine (4 papers)Molecular Imaging and Biology (3 papers)Pharmaceuticals (3 papers)Molecular Pharmaceutics (3 papers)Contrast Media & Molecular Imaging (3 papers)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Catarina Xavier
59 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Radiology, Nuclear Medicine and Imaging 2.6k
- Oncology 1.3k
- Immunology 600
- Molecular Biology 1.3k
- Immunology and Allergy 92
Countries citing papers authored by Catarina Xavier
This map shows the geographic impact of Catarina Xavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catarina Xavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catarina Xavier more than expected).
Fields of papers citing papers by Catarina Xavier
This network shows the impact of papers produced by Catarina Xavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catarina Xavier. The network helps show where Catarina Xavier may publish in the future.
Co-authors
The 25 scholars most cited alongside Catarina Xavier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 26 | |
| 2 | 2021 | 143 | |
| 3 | 2020 | 45 | |
| 4 | 2020 | 54 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 79 | |
| 7 | 2018 | 16 | |
| 8 | 2018 | 47 | |
| 9 | 2017 | 55 | |
| 10 | 2017 | 141 | |
| 11 | 2017 | 40 | |
| 12 | Preclinical evaluation of astatinated nanobodies for targeted alpha therapy | 2017 | 1 |
| 13 | 2016 | 100 | |
| 14 | 2016 | 80 | |
| 15 | 2014 | 181 | |
| 16 | 2014 | 149 | |
| 17 | 2012 | 44 | |
| 18 | 2012 | 18 | |
| 19 | 2011 | 265 | |
| 20 | 2010 | 35 |
About Catarina Xavier
Catarina Xavier is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Allergy, Immunology and Molecular Biology, having authored 59 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (39 papers), Radiopharmaceutical Chemistry and Applications (37 papers), HER2/EGFR in Cancer Research (13 papers), Medical Imaging Techniques and Applications (11 papers), Peptidase Inhibition and Analysis (9 papers), Protein purification and stability (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.6k citations), Oncology (1.3k citations), Immunology (600 citations), Molecular Biology (1.3k citations) and Immunology and Allergy (92 citations). Catarina Xavier has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Nick Devoogdt, Vicky Caveliers, Tony Lahoutte, Serge Muyldermans, Matthias D’Huyvetter, Ilse Vaneycken, Marleen Keyaerts, Sam Massa, Cécile Vincke and Jens De Vos. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Imaging and Biology, Pharmaceuticals, Molecular Pharmaceutics and Contrast Media & Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.